Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03029806 · ClinicalTrials.gov registry record · NA

Lysine-specific Demethylase 1 and Salt-sensitivity in Humans

A NA study of Healthy Subjects, sponsored by Brigham and Women's Hospital.

Active
Registry status
NA
Development phase
88
Enrollment target
1
Study location

NCT03029806 is a NA study of Healthy Subjects that is active but no longer recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 88 participants, below the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03029806, a NA study of Healthy Subjects, is active but no longer recruiting, sponsored by Brigham and Women's Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
88 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the role dietary salt plays in epigenetic regulation of blood pressure, focusing on the salt-sensitive regulatory enzyme Lysine-specific demethylase 1.

Conditions Studied

Interventions

  • OTHER Aldosterone response to AngII LS
  • OTHER Renal blood flow response to salt
  • OTHER Vascular Stiffness

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2017-01-02
Est. Completion 2026-06-01
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT03029806

The ClinicalTrials.gov registry entry for NCT03029806 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 127-participant average among 69 other Healthy Subjects trials with a reported enrollment target (31% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy Subjects appearing as the primary indexed condition, and to 3 interventions - of which Aldosterone response to AngII LS is the first listed.

NCT03029806 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03029806 about?

NCT03029806 is a clinical study titled "Lysine-specific Demethylase 1 and Salt-sensitivity in Humans". The purpose of this study is to investigate the role dietary salt plays in epigenetic regulation of blood pressure, focusing on the salt-sensitive regulatory enzyme Lysine-specific demethylase 1.

What is the current status of trial NCT03029806?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 88 participants. The study started on 2017-01-02. Estimated completion is 2026-06-01.

What conditions does trial NCT03029806 study?

This clinical trial studies the following conditions: Healthy Subjects.

What interventions are being tested in trial NCT03029806?

The interventions under investigation include: Aldosterone response to AngII LS (OTHER), Renal blood flow response to salt (OTHER), Vascular Stiffness (OTHER).

Who is sponsoring clinical trial NCT03029806?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03029806 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Subjects

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.